STOCK TITAN
  1. Home
  2. Sec-filings
  3. IDXX
  4. [ARS] IDEXX LABORATORIES INC /DE SEC Filing

[ARS] IDEXX LABORATORIES INC /DE SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - IDEXX LABORATORIES INC /DE

ARS Filing - IDEXX LABORATORIES INC /DE

This filing is available as a PDF document.

Filing Type: ARS

Company: IDEXX LABORATORIES INC /DE (IDXX)

Acceptance Date: 2026-03-27T16:01:22.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

IDEXX Laboratories

NASDAQ:IDXX

View IDXX Stock Overview →

IDXX Rankings

#320 Ranked by Market Cap
N/A Ranked by Dividends

IDXX Latest News

Feb 12, 2026
IDEXX Laboratories to Present at Two Institutional Investor Conferences
Feb 2, 2026
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
Jan 15, 2026
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
Jan 15, 2026
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
Jan 13, 2026
IDEXX Announces CEO Succession

IDXX Latest SEC Filings

Mar 27, 2026
[DEF 14A] IDEXX LABORATORIES INC /DE Definitive Proxy Statement
Mar 27, 2026
[SCHEDULE 13G/A] IDEXX LABORATORIES INC /DE Amended Passive Investment Disclosure
Mar 26, 2026
[8-K] IDEXX LABORATORIES INC /DE Reports Material Event
Mar 13, 2026
[PRE 14A] IDEXX LABORATORIES INC /DE Preliminary Proxy Statement
Mar 5, 2026
[Form 4] IDEXX LABORATORIES INC /DE Insider Trading Activity

IDXX Stock Data

45.65B
79.04M
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
WESTBROOK